drugset / Trial / NCT02893098

A Study to Evaluate the Safety and Efficacy of Humia Inj. in Patients With Symptomatic Osteoarthritis of the Knee

NCT02893098 ↗

Phase 3 Completed 232 enrolled Huons Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

A Multi-Centre, Parallel, Double-Blind, Active comparator, Randomised phase III Clinical Trial

Timeline

Start
2016-08
Primary completion
2017-10
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator High hyal Plus Unknown 2 ml —
Subject Humia Unknown 3 ml —

Indications